254 related articles for article (PubMed ID: 35311705)
1. Oscillatory Activity of the Hippocampus in Prodromal Alzheimer's Disease: A Source-Space Magnetoencephalography Study.
Luppi JJ; Schoonhoven DN; van Nifterick AM; Gouw AA; Hillebrand A; Scheltens P; Stam CJ; de Haan W
J Alzheimers Dis; 2022; 87(1):317-333. PubMed ID: 35311705
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal Oscillatory Patterns During Working Memory Maintenance in Mild Cognitive Impairment and Subjective Cognitive Decline.
Serrano N; López-Sanz D; Bruña R; Garcés P; Rodríguez-Rojo IC; Marcos A; Crespo DP; Maestú F
Int J Neural Syst; 2020 Jan; 30(1):1950019. PubMed ID: 31522594
[TBL] [Abstract][Full Text] [Related]
3. A multiscale brain network model links Alzheimer's disease-mediated neuronal hyperactivity to large-scale oscillatory slowing.
van Nifterick AM; Gouw AA; van Kesteren RE; Scheltens P; Stam CJ; de Haan W
Alzheimers Res Ther; 2022 Jul; 14(1):101. PubMed ID: 35879779
[TBL] [Abstract][Full Text] [Related]
4. Complexity changes in preclinical Alzheimer's disease: An MEG study of subjective cognitive decline and mild cognitive impairment.
Shumbayawonda E; López-Sanz D; Bruña R; Serrano N; Fernández A; Maestú F; Abasolo D
Clin Neurophysiol; 2020 Feb; 131(2):437-445. PubMed ID: 31884374
[TBL] [Abstract][Full Text] [Related]
5. Slowing of Hippocampal Activity Correlates with Cognitive Decline in Early Onset Alzheimer's Disease. An MEG Study with Virtual Electrodes.
Engels MM; Hillebrand A; van der Flier WM; Stam CJ; Scheltens P; van Straaten EC
Front Hum Neurosci; 2016; 10():238. PubMed ID: 27242496
[TBL] [Abstract][Full Text] [Related]
6. Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer's disease.
Nakamura A; Cuesta P; Fernández A; Arahata Y; Iwata K; Kuratsubo I; Bundo M; Hattori H; Sakurai T; Fukuda K; Washimi Y; Endo H; Takeda A; Diers K; Bajo R; Maestú F; Ito K; Kato T
Brain; 2018 May; 141(5):1470-1485. PubMed ID: 29522156
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal resting-state EEG in amyloid-positive patients along the Alzheimer's disease continuum: considerations for clinical trials.
Scheijbeler EP; de Haan W; Stam CJ; Twisk JWR; Gouw AA
Alzheimers Res Ther; 2023 Oct; 15(1):182. PubMed ID: 37858173
[TBL] [Abstract][Full Text] [Related]
8. Alpha band disruption in the AD-continuum starts in the Subjective Cognitive Decline stage: a MEG study.
López-Sanz D; Bruña R; Garcés P; Camara C; Serrano N; Rodríguez-Rojo IC; Delgado ML; Montenegro M; López-Higes R; Yus M; Maestú F
Sci Rep; 2016 Nov; 6():37685. PubMed ID: 27883082
[TBL] [Abstract][Full Text] [Related]
9. Resting state EEG biomarkers of cognitive decline associated with Alzheimer's disease and mild cognitive impairment.
Meghdadi AH; Stevanović Karić M; McConnell M; Rupp G; Richard C; Hamilton J; Salat D; Berka C
PLoS One; 2021; 16(2):e0244180. PubMed ID: 33544703
[TBL] [Abstract][Full Text] [Related]
10. MEG spectral analysis in subtypes of mild cognitive impairment.
López ME; Cuesta P; Garcés P; Castellanos PN; Aurtenetxe S; Bajo R; Marcos A; Delgado ML; Montejo P; López-Pantoja JL; Maestú F; Fernandez A
Age (Dordr); 2014 Jun; 36(3):9624. PubMed ID: 24532390
[TBL] [Abstract][Full Text] [Related]
11. Network Disruption in the Preclinical Stages of Alzheimer's Disease: From Subjective Cognitive Decline to Mild Cognitive Impairment.
López-Sanz D; Garcés P; Álvarez B; Delgado-Losada ML; López-Higes R; Maestú F
Int J Neural Syst; 2017 Dec; 27(8):1750041. PubMed ID: 28958179
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiological brain signatures for the classification of subjective cognitive decline: towards an individual detection in the preclinical stages of dementia.
López-Sanz D; Bruña R; Delgado-Losada ML; López-Higes R; Marcos-Dolado A; Maestú F; Walter S
Alzheimers Res Ther; 2019 Jun; 11(1):49. PubMed ID: 31151467
[TBL] [Abstract][Full Text] [Related]
13. MEG delta mapping along the healthy aging-Alzheimer's disease continuum: diagnostic implications.
Fernández A; Turrero A; Zuluaga P; Gil-Gregorio P; del Pozo F; Maestu F; Moratti S
J Alzheimers Dis; 2013; 35(3):495-507. PubMed ID: 23478303
[TBL] [Abstract][Full Text] [Related]
14. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
15. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
16. MEG Oscillatory Slowing in Cognitive Impairment is Associated with the Presence of Subjective Cognitive Decline.
Bruña R; López-Sanz D; Maestú F; Cohen AD; Bagic A; Huppert T; Kim T; Roush RE; Snitz B; Becker JT
Clin EEG Neurosci; 2023 Jan; 54(1):73-81. PubMed ID: 35188831
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and Other Dementias.
Bao YW; Chau ACM; Chiu PK; Shea YF; Kwan JSK; Chan FHW; Mak HK
J Alzheimers Dis; 2021; 79(2):819-832. PubMed ID: 33361593
[TBL] [Abstract][Full Text] [Related]
18. Characterizing the fluctuations of dynamic resting-state electrophysiological functional connectivity: reduced neuronal coupling variability in mild cognitive impairment and dementia due to Alzheimer's disease.
Núñez P; Poza J; Gómez C; Rodríguez-González V; Hillebrand A; Tola-Arribas MA; Cano M; Hornero R
J Neural Eng; 2019 Sep; 16(5):056030. PubMed ID: 31112938
[TBL] [Abstract][Full Text] [Related]
19. Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
King-Robson J; Wilson H; Politis M;
J Alzheimers Dis; 2021; 82(2):541-560. PubMed ID: 34057079
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
